Medical Device Network on MSN14d
Medtronic announces two-year trial outcomes of Evolut TAVR
Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.
drugdeliverybusiness5d
Medtronic reports first real-world data on smart insulin pen system
The Smart MDI system featuring the InPen and Simplera systems. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM ...
Yahoo Finance13d
Medtronic Named One of the 2025 World’s Most Ethical Companies for the Third Time by Ethisphere
NORTHAMPTON, MA / ACCESS Newswire / March 11, 2025 / Medtronic, a global leader in healthcare technology, today announced it has received the 2025 World's Most Ethical Companies® recognition by ...
FDA issues Medtronic embolization device recall and correction notice
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
Nasdaq3d
Looking At Medtronic's Recent Unusual Options Activity
High-rolling investors have positioned themselves bullish on Medtronic (NYSE:MDT), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...